Traditional Chinese medicine extract for treating cardiac conduction block and application thereof

Abstract

The invention relates to a traditional Chinese medicine extract for treating cardiac conduction block. The traditional Chinese medicine extract is characterized by being prepared from, by weight, 0.05-1% of ferulic acid, 0.02-0.05% of ergosta, 0.02-0.05% of glycoside cinnamaldehyde, 0.02-0.05% of eugenol, 1-2% of coenzyme Q1 and 0.05-1% of dracorhodin. The traditional Chinese medicine extract has the advantages of capability of removing stasis and easing pain, stopping bleeding and promoting granulation and functions of improving human immunity, enhancing resistance to oxidation, delaying senescence and improving human vitality.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine extract for treating heart block and its application. Background technique [0002] Heart block is a slowing or blocking of the conduction of impulses anywhere in the heart's conduction system. If it occurs between the sinoatrial node and the atrium, it is called sinoatrial block. Between the atrium and ventricle, called atrioventricular block. Located in the ventricle, called intraventricular block. According to the severity of the conduction block, currently commonly used isoproterenol is effective for any part of the atrioventricular block, but it should be used with caution when used in acute myocardial infarction, because it may cause severe ventricular arrhythmia, so the drug is only Emergency, temporary, palliative-based treatment, prone to serious adverse reactions, is only applicable to emergency situations without ...

AI Technical Summary

Problems solved by technology

According to the severity of the conduction block, currently commonly used isoproterenol is effective for any part of the atrioventricular block, but it should be used with caution when used in acute myocardial infarction, because it may cause severe ventricular arrhythmia, so the drug is only Emergency, temporary, palliative-based treatment, prone to serious adverse reactions, only applicable to emergency situations without cardiac pacing conditions

Therefore, for those with obvious symptoms and slow ventricular rate, temporary or permanent cardiac pacing therapy is often given, which brings a lot of trouble to the patient's activities.